Skip to main content

Find a trial

Find a trial

Trial status
Trial Phase
Trial type
19 clinical trials grid list download
  • Title Organ Phase Statut Major inclusion criteria Contact
  • 1367.1 An open label, Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies, with repeated administration in patients with clinical benefit Multiple phase 1 Closed any line, RECIST 1.1 Ahmad Hussein Awada
  • AMC303-01 A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin Multiple phase 1/1b Closed any line, RECIST 1.1 Philippe Aftimos
  • CheckMate A Randomized, Multi-center Phase III Study of Nivolumab versus Sorafenib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (CheckMate 459: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 459) Liver phase 3 Closed Not eligible for surgery Alain Hendlisz
  • CIRT CIRSE Registry for SIR-Spheres Therapy (CIRT) Liver Closed Treatment with SIR-sphères microspheres Patrick Flamen
  • EORTC 1658 Qualification of imaging methods to assess cancer drug induced interstitial lung disease (ImageILD) Lung Closed any line / Lung metastasis Konstantinos Stathopoulos
  • GNS561-CL-I-Q-0211 New Title: Phase 1/2a study to evaluate the safety, activity, and pharmacokinetics of escalating doses of GNS561 in patients with primary or secondary liver cancer.
    (Old Title: Phase 1/2a study to evaluate the safety, activity, and pharmacokinetics of escalating doses of GNS561 in patients with primary liver cancer)
    Multiple phase 1 Closed RECIST v1.1 Ahmad Hussein Awada
  • I7W-MC-JQBA A Phase 1 Study of LY3127804 as Monotherapy and in Combination with Ramucirumab in Patients with Advanced Solid Tumors Multiple phase 1 Closed RECIST 1.1, after standard trerapy Ahmad Hussein Awada
  • IJB_2672 A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older Multiple phase 3 Closed vaccine, diarrhea, clostridium
  • IJB_2728 Improving emotion regulation for patients with metastatic cancer: A pilot study assessing the impact of a multi-component psychological group intervention Solid tumors Open Metastatic, any tumors
  • IJB_2732 A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination with Anti-PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors Multiple phase 1/1b Closed Metastatic, Biopsy mandatory Nuria Kotecki
  • INCAGN1876-201 A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies Multiple phase 1 Closed second line, RECIST 1.1, Biopsy Philippe Aftimos
  • INCB 01158-203 A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of INCB001158 in Combination With Chemotherapy, in Subjects With Advanced or Metastatic Solid Tumors. (INCB01158-203) Multiple phase 1 Closed Metastatic, Biopsy mandatory Christiane Jungels
  • INCB59872-101 A Phase 1/2, Open-Label, Dose-Escalation / Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies Solid tumors phase 1/2 Closed Any line Ahmad Hussein Awada
  • INCB62079-101 A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies Multiple phase 1 Closed after standard therapy Christiane Jungels